Literature DB >> 9808106

Nephropathy of type-2 diabetes mellitus.

P Ruggenenti1, G Remuzzi.   

Abstract

Entities:  

Mesh:

Year:  1998        PMID: 9808106     DOI: 10.1681/ASN.V9112157

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  20 in total

1.  Metformin prevents the impairment of endothelium-dependent vascular relaxation induced by high glucose challenge in rabbit isolated perfused kidneys.

Authors:  M B Gomes; S Cailleaux; E Tibiriçá
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2005-08-26       Impact factor: 3.000

2.  Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice.

Authors:  Yi Lin; Makoto Kuro-o; Zhongjie Sun
Journal:  Endocrinology       Date:  2013-08-08       Impact factor: 4.736

Review 3.  The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy.

Authors:  P Anil Kumar; Frank C Brosius; Ram K Menon
Journal:  Curr Diabetes Rev       Date:  2011-01

4.  Moderate exercise attenuates caspase-3 activity, oxidative stress, and inhibits progression of diabetic renal disease in db/db mice.

Authors:  S Ghosh; M Khazaei; F Moien-Afshari; L S Ang; D J Granville; C B Verchere; S R Dunn; P McCue; A Mizisin; K Sharma; I Laher
Journal:  Am J Physiol Renal Physiol       Date:  2009-01-14

Review 5.  Optimizing target-organ protection in patients with diabetes mellitus: angiotensin-converting enzyme inhibitors or angiotensin receptor blockers?

Authors:  Wei X Lu; Jay Lakkis; Matthew R Weir
Journal:  Curr Hypertens Rep       Date:  2003-06       Impact factor: 5.369

Review 6.  Diabetic nephropathy-pathophysiology and management.

Authors:  Judy Tan Shumway; Steven R Gambert
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 7.  The role of sulodexide in the treatment of diabetic nephropathy.

Authors:  Ram Weiss; Robert Niecestro; Itamar Raz
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathy.

Authors:  E Nelaj; M Gjata; I Lilaj; G Burazeri; E Sadiku; L Collaku; O Bare; M Tase
Journal:  Hippokratia       Date:  2008       Impact factor: 0.471

9.  Klotho attenuates renal hypertrophy and glomerular injury in Ins2Akita diabetic mice.

Authors:  Hiroyuki Kadoya; Minoru Satoh; Yoshisuke Haruna; Tamaki Sasaki; Naoki Kashihara
Journal:  Clin Exp Nephrol       Date:  2015-11-19       Impact factor: 2.801

10.  Diabetic nephropathy.

Authors:  Themis Zelmanovitz; Fernando Gerchman; Amely Ps Balthazar; Fúlvio Cs Thomazelli; Jorge D Matos; Luís H Canani
Journal:  Diabetol Metab Syndr       Date:  2009-09-21       Impact factor: 3.320

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.